Article

June 1, 2004

New insights from around the world to be featured

New this year: A rapid-fire paper session consisting of almost 30 cutting-edge refractive surgery-based papers from around the world.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos

1 expert is featured in this series.

1 expert is featured in this series.

1 expert is featured in this series.

1 expert is featured in this series.

Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting

Related Content

FDA approves prednisolone acetate ophthalmic suspension for treating steroid-responsive ocular inflammation

June 12th 2025

FDA approves prednisolone acetate ophthalmic suspension for treating steroid-responsive ocular inflammation

3 Things You Should Know About the GA Pipeline

June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Formosa Pharmaceuticals grants Harrow US commercial rights to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia

June 12th 2025

Formosa Pharmaceuticals grants Harrow US commercial rights to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia

Patient-Centered Treatment Strategies in the Management of nAMD and DME

May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Zeteo Biomedical secures US and EU patents for drug delivery technologies

June 12th 2025

Zeteo Biomedical secures US and EU patents for drug delivery technologies

NIH study identifies brain circuits critical to visual acuity beyond the retina

June 12th 2025

NIH study identifies brain circuits critical to visual acuity beyond the retina

Related Content

FDA approves prednisolone acetate ophthalmic suspension for treating steroid-responsive ocular inflammation

June 12th 2025

FDA approves prednisolone acetate ophthalmic suspension for treating steroid-responsive ocular inflammation

3 Things You Should Know About the GA Pipeline

June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Formosa Pharmaceuticals grants Harrow US commercial rights to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia

June 12th 2025

Formosa Pharmaceuticals grants Harrow US commercial rights to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia

Patient-Centered Treatment Strategies in the Management of nAMD and DME

May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Zeteo Biomedical secures US and EU patents for drug delivery technologies

June 12th 2025

Zeteo Biomedical secures US and EU patents for drug delivery technologies

NIH study identifies brain circuits critical to visual acuity beyond the retina

June 12th 2025

NIH study identifies brain circuits critical to visual acuity beyond the retina

Editorial Board

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.